You have searched for "US drug company"

Showing 41-50 of 222

Sort by: Newest | Oldest | Relevance

Global Trends 10 Apr 2017 | 12:00 AM

Reflections on World Health Day

There is nothing as precious as good health, the basis of life itself. But the goal of providing healthcare for all is still elusive.

Corporate News 14 Mar 2017 | 11:03 PM

Ackman's Pershing Square sells Valeant stake, takes US$3bil loss

BOSTON: Billionaire investor William Ackman walked away from Valeant Pharmaceuticals International Inc on Monday with a loss of more than $3 billion as he sold his entire stake in the struggling drug company after trying to rescue it for some 18 months

Community 15 Dec 2016 | 12:00 AM

Drug company’s new R&D facility set to become operational

HOVID Bhd has set up a bio-equivalence (BE) studies centre at Bayan Lepas, Penang to enhance its pharmaceutical research and development.

Corporate News 06 Dec 2016 | 6:13 AM

Trump's corporate tax holiday could spur pharma M&A

NEW YORK: US President-elect Donald Trump's plan to incentivise US companies to repatriate their swelling overseas cash piles could spur a new wave of dealmaking in a pharmaceutical industry seeking to buy its way into growth.

Global Trends 26 Sep 2016 | 12:00 AM

Leaders pledge action to control superbugs

World leaders at the Summit of the UN General Assembly spoke on the need to save millions of lives by controlling the crisis of antibiotic resistance and adopted a landmark political declaration calling for global action.

Business 06 Sep 2016 | 12:00 AM

China Resources Pharma seeks nod for US$2bil IPO

HONG KONG: China Resources Holdings Co’s pharmaceutical unit is planning to seek approval from the Hong Kong stock exchange this week to go ahead with an initial public offering (IPO) that may raise as much as US$2bil, according to people familiar with the matter.

TECH 01 Sep 2016 | 4:00 AM

US slams EU, but Apple tax demand first issued in Washington

The United States is furious at the European Union for handing Apple Inc a US$14.5bil (RM59.17bil) tax demand on Aug 30 but EU officials say it was Washington which put them on to the scheme in the first place.

Corporate News 22 Aug 2016 | 7:40 PM

Pfizer boosts cancer drug roster with US$14bil Medivation deal

NEW YORK: Pfizer Inc, beating out numerous other bidders, said it would buy US cancer drug company Medivation Inc for US$14bil (RM56.3bil) in cash, adding its blockbuster prostate cancer drug Xtandi to the company’s growing oncology roster.

Corporate News 22 Aug 2016 | 5:23 AM

Pfizer nears deal to acquire Medivation for close to US$14b

New York: Pfizer Inc is in advanced talks to acquire US cancer drug company Medivation Inc for close to US$14 billion, as it seeks to boost its oncology portfolio, people familiar with the matter said on Sunday.

Business 22 Aug 2016 | 1:24 AM

Breakfast briefing: Monday, August 22

Breakfast briefing: Monday, August 22